Evidence map›Paper›PMID 42135890›Full record

ArticleAnimal models and experimental medicine2026

Evaluation of cardiac histology and cell death markers during the progression of diabetes in a streptozotocin-induced diabetes rat model.

Tamara Sáez, Ivo Carrasco-Wong, Juan Varas, Sebastián San Martín, Jaime A Riquelme, Rienzi Díaz-Navarro

Abstract read
In one paragraph

Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tamara SáezDepartment of Internal Medicine, Cardiovascular Physiology Laboratory, Universidad de Valparaíso, Valparaíso, Chile.
Ivo Carrasco-WongCellular Signaling and Differentiation Laboratory (CSDL), School of Medical Technology, Medicine and Science Faculty, Universidad San Sebastián, Santiago, Chile.
Juan VarasCenter of Interdisciplinary Biomedical and Engineering Research for Health (MEDING), Universidad de Valparaíso, Valparaíso, Chile.
Sebastián San MartínCenter of Interdisciplinary Biomedical and Engineering Research for Health (MEDING), Universidad de Valparaíso, Valparaíso, Chile.
Jaime A RiquelmeDepartamento de Química Farmacológica y Toxicológica, Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile, Santiago, Chile.
Rienzi Díaz-NavarroDepartment of Internal Medicine, Cardiovascular Physiology Laboratory, Universidad de Valparaíso, Valparaíso, Chile.ORCID https://orcid.org/0000-0002-5493-0735

Funding

Chilean National Agency for Research and Development (ANID, Agencia Nacional de Investigación y Desarrollo)FONDECYT de Iniciación 11241417FONDECYT de Iniciación 11251077
6 · The paper itself

Abstract

The simultaneous characterization of histological alterations and distinct cell death pathways associated with diabetic cardiomyopathy (DCM) has not been comprehensively explored and may differ depending on the experimental model. We evaluated cardiac histological changes and markers of apoptosis, cell death associated with mitochondrial permeability transition pore (mPTP) opening (necrosis), and autophagy in early and advanced stages of streptozotocin (STZ)-induced diabetes in rats receiving insulin daily to prevent mortality while maintaining hyperglycemia. Adult male Sprague-Dawley rats (n = 4-5) were randomly assigned to receive STZ (diabetic group) or saline (mock) and followed up for 4 or 12 weeks. Hearts were processed for histological examination and immunohistochemical detection of active caspase-3, beclin-1, and cyclophilin D. STZ significantly increased glycemia at both time points, whereas body weight reduction was observed only at 12 weeks. No evidence of cardiac hypertrophy, fibrosis, or structural injury was detected in diabetic rats at either stage. Expression of caspase-3, beclin-1, and cyclophilin D decreased at 12 weeks compared with 4 weeks, regardless of treatment; however, cyclophilin D was elevated in diabetic hearts at 4 weeks. These results suggest an early susceptibility to mPTP opening under persistent hyperglycemia, despite the absence of overt histological damage. They also underscore the critical importance of insulin dosing and study duration when interpreting data from STZ-based models. Further studies are warranted to determine how even minimal insulin administration may shape the temporal dynamics of cell death during the progression of DCM.

Indexed as

Diabetes Mellitus, ExperimentalDiabetic CardiomyopathiesMyocardiumAnimalsApoptosisAutophagyBeclin-1BiomarkersCaspase 3Cell DeathCyclophilinsDisease Models, AnimalDisease ProgressionInsulinMaleMitochondrial Membrane Transport ProteinsBeclin-1BiomarkersCaspase 3CyclophilinsInsulinMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PorePeptidyl-Prolyl Isomerase FStreptozocincell death markersdiabetic cardiomyopathyhistologyinsulinstreptozotocin‐induced diabetic rats

Identifiers

PMID42135890
PMCPMC13383912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.